Sildenafil Citrate
Product Images NDC 50436-0005

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 50436-0005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504360005)

Sildenafil Citrate 20 mg blister card label from Unit Dose Services, NDC 50436-0005-1. The label specifies one tablet per pouch in a unit dose pouch with 20 mg sildenafil strength. It includes dispensing instructions, manufacturer information, storage warnings, and a barcode at the bottom.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

A Kaplan-Meier survival curve displaying estimated cumulative mortality rate (%) over time in years for three dose groups labeled High Dose, Medium Dose, and Low Dose. The graph shows the number of subjects at risk at several time points (0 to 5 years) for each dose group, with mortality rates increasing across the three dosages over time.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

A forest plot chart illustrating the fold change and 90% confidence interval in pharmacokinetic parameters (AUC and Cmax) of Sildenafil when coadministered with various interacting drugs. The chart includes recommendations regarding dose adjustments, indicating most drugs require no dose change except ritonavir, for which coadministration is not recommended.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

A chart depicting fold change and 90% confidence intervals for various drugs interacting with sildenafil citrate, measuring parameters such as INR AUC, Cmax, AUC, and bleeding time. The graph compares fold change relative to the interacting drug alone on a scale from 0.5 to 2, presenting recommendations primarily indicating no dose adjustment, except for ritonavir with a note that coadministration is not recommended.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

A line plot showing change from baseline measured in meters over weeks 4, 8, and 12 of a study for four groups: Placebo, Sildenafil 20mg TID, Sildenafil 40mg TID, and Sildenafil 80mg TID. The y-axis represents change from baseline in meters, and the x-axis represents the study week. Error bars indicate variability in measurements for each group at each time point.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

A forest plot chart illustrating the placebo-corrected change in 6-minute walk distance (meters) for Sildenafil 20 mg TID across various subgroups including baseline walk distance, etiology, PH criteria, gender, age, mean PAP, and PVRI. The chart shows point estimates and confidence intervals for each subgroup comparison between placebo and Sildenafil groups.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

A line chart comparing the percentage without a clinically worsening event over time between placebo and Sildenafil groups. The x-axis represents days from randomization, ranging from 0 to 112 days. The y-axis shows the percentage without clinical worsening, ranging from 0 to 100%. Two lines indicate the outcomes for placebo (solid line) and Sildenafil (dashed line), with Sildenafil maintaining a higher percentage throughout the period.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

A line plot showing mean change from baseline in meters over a 12-week study period for Sildenafil Citrate at doses of 1 mg, 5 mg, and 20 mg taken three times daily (TID). The x-axis represents weeks of study (4, 8, and 12), and the y-axis shows change from baseline in meters, with error bars indicating standard error for each treatment at each visit.*

FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

Chemical structure of Sildenafil Citrate showing its molecular formula with labeled chemical bonds and groups, including ethoxyphenyl, methylpiperazine, and citrate components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.